Prodia Diagnostic Line is trading at IDR 314 (-5.42%) as the stock undergoes a sharp post-IPO pullback following a period of volatile price discovery.
- The decline follows a recent surge where the stock traded above its offering price, prompting early investors to lock in profits.
- No company-specific catalysts were reported for July 21, suggesting the move is primarily driven by market normalization after the initial IPO rally.